Compare Tencent Music Entertainment Group - ADR (TME) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tencent Music Entertainment Group - ADR vs State Street SPDR S&P Biotech ETF — how do they compare? Tencent Music Entertainment Group - ADR trades at $8.39 (market cap $12.83B), while State Street SPDR S&P Biotech ETF trades at $153.76 (market cap $10.11B). The key difference: Tencent Music Entertainment Group - ADR is the larger of the two by market cap, and Tencent Music Entertainment Group - ADR pays a 3.02% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tencent Music Entertainment Group - ADR for 67 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| TME | XBI | |
|---|---|---|
Market Cap | $12.83B | $10.11B |
Volume | 3,618,478 | 12,903,266 |
Sector | Media | Broad Market / Factor |
52-Week High | $23.71 | $169.55 |
52-Week Low | $7.74 | $104.99 |
Typical Hold Time | 67 Days | 38 Days |
Enterprise Value | $10.77B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TME trades at $8.38, up 4.88% today, but technical indicators are bearish overall. The company reported strong 2025 results with revenue of $32.9B and net income of $11.06B, though recent quarters show mixed earnings performance. Analyst sentiment is mixed with a consensus price target of $12.50, and the stock appears undervalued with a P/E of 9.33 and P/S of 2.46.
The outlook is balanced: attractive valuation and profitability support upside potential, but bearish technicals, competitive pressures, and recent net cash outflows pose risks. Investors should weigh strong fundamentals against near-term headwinds and market sentiment.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
